Burnaby, Canada

Arbutus Biopharma Corporation


Patents = 56

Trademarks = 4

Forward Citations = 331


where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents


210 inventors (with patents filed for the assignee):


Arbutus Biopharma Corporation is a publicly traded biopharmaceutical company dedicated to discovering, developing, and commercializing a cure for patients suffering from chronic hepatitis B virus (HBV) infection. With an experienced team and a strong pipeline of innovative therapeutic candidates, Arbutus aims to transform the lives of millions affected by this devastating disease. The company's research focuses on advancing a range of drug candidates, including RNA interference (RNAi) -based therapeutics, gene editing technologies, and combination therapies.
This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com
Loading…